Evidence map›Paper›PMID 30421083›Full record

ArticleSurgical endoscopy2019

New experience of endoscopic papillectomy for ampullary neoplasms.

Shuling Li, Zikai Wang, Fengchun Cai, Enqiang Linghu, Gang Sun, Xiangdong Wang, Jiangyun Meng, Hong Du, Yunsheng Yang, Wen Li

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Updates on the Management of Ampullary Neoplastic Lesions.Diagnostics (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Benefits ofEuropean radiology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shuling LiDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Zikai WangDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Fengchun CaiDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Enqiang LinghuDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Gang SunDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Xiangdong WangDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Jiangyun MengDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Hong DuDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Yunsheng YangDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China.
Wen LiDepartment of Gastroenterology and Hepatology, Chinese PLA General Hospital, 28#, Fuxing Road, Beijing, 100853, China. liwen2000@yahoo.com.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo establish the clinical value of endoscopic papillectomy for duodenal papillary tumor based on endoscopic and clinical characteristics. PATIENTS AND

methodsThis single-center, retrospective study included 110 patients with duodenal papillary tumor who underwent endoscopic papillectomy between January 2006 and April 2017 at the gastrointestinal endoscopic center of the Chinese PLA General Hospital. Clinical data, postoperative pathology, procedure-related complications, and therapeutic outcomes were analyzed.

resultsEndoscopic papillectomy was technically feasible in all patients, and was mainly performed by four experienced endoscopists. The primary success rate of endoscopic papillectomy for ampullary neoplasms was 78.2%. A total of 13 patients experienced recurrence during a mean follow-up period of 16.28 months (range 6-132 months), the predictive factors that were related to recurrence were complete resection (53.8% vs. 94.2%; P = 0.001), and final pathology findings (P = 0.001). Delayed hemorrhage, the most common procedure-related complication, occurred in 20% (22/110) of patients and was significantly related to intraoperative bleeding (P = 0.042). Pancreatitis was the second most common complication, which was closely related to intraoperative bleeding requiring intervention (P = 0.040) and larger tumor size (P = 0.044). Histology, type of resection, stent placement, sphincterotomy, and duration of procedure were not related to post-procedure hemorrhage or pancreatitis. Older age (63.7 ± 13.5 vs. 57.4 ± 12.2; P = 0.033), jaundice (47.8% vs. 13.8%; P = 0.001), endoscopic forceps biopsy diagnosis of high-grade intraepithelial neoplasia (82.6% vs. 14.9%; P = 0.001), tumor size ≥ 2 cm (60.9% vs. 34.5%; P = 0.022), and dilation of the bile duct (34.8% vs. 9.2%; P = 0.006) were clinical features for ampullary carcinoma. The rate of complete resection (52.2% vs. 92.0%; P = 0.001) and recurrence (34.8% vs. 6.8%; P = 0.001) were also related to the diagnosis of ampullary carcinoma at final pathology.

conclusionsEndoscopic papillectomy is a feasible and reasonable option for both diagnosis and treatment of tumors of the duodenal papilla in properly selected patients.

Indexed as

Ampulla of VaterDuodenal NeoplasmsEndoscopy, Digestive SystemAdultAgedBiopsyFeasibility StudiesFemaleHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesTreatment OutcomeDuodenal papillaEndoscopyLesionNeoplasmPathology

Identifiers

PMID30421083
OpenAlexW2900898203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.